Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to $2 billion by James Thorne on January 4, 2019January 5, 2019 at 10:51 am Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition to the up-front payment, Adaptive could receive up to $2… Read More